Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Immunotherapy, Adoptive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03720496
What this trial is testing

Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With CD19-TriCART Cell Therapy

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Timmune Biotech Inc. 6
Early research (Phase 1)Study completedNCT05451212
What this trial is testing

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

Who this might be right for
MuSK Myasthenia Gravis
Cabaletta Bio 7
Testing effectiveness (Phase 2)UnknownNCT03754764
What this trial is testing

A Feasibility and Safety Study of CD38 CAR-T Cell Immunotherapy for Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T Adoptive Cellular Immunotherapy

Who this might be right for
Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T ACI
Chinese PLA General Hospital 80
Testing effectiveness (Phase 2)Study completedNCT02424916
What this trial is testing

Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study

Who this might be right for
Metastatic Melanoma
Nantes University Hospital 7
Early research (Phase 1)Study completedNCT01445132
What this trial is testing

Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation

Who this might be right for
Chronic Lymphocytic Leukemia
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)UnknownNCT02632006
What this trial is testing

Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Second Military Medical University 40
Early research (Phase 1)Study completedNCT03244306
What this trial is testing

CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma

Who this might be right for
Leukemia
Seattle Children's Hospital 4
Early research (Phase 1)Study completedNCT04217473
What this trial is testing

TNFalpha and Interleukin 2 Coding Oncolytic Adenovirus TILT-123 During TIL Treatment of Advanced Melanoma

Who this might be right for
Metastatic Melanoma
TILT Biotherapeutics Ltd. 17
Not applicableEnrolling By InvitationNCT03226704
What this trial is testing

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

Who this might be right for
LeukemiaLymphomaAcute Lymphoblastic Leukemia+2 more
National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Looking for participantsNCT06364423
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellB-Lymphocytic Leukemia, ChronicB-Cell Chronic Lymphocytic Leukemia+4 more
National Cancer Institute (NCI) 132
Testing effectiveness (Phase 2)WithdrawnNCT04536922
What this trial is testing

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab

Who this might be right for
Metastatic HPV-16 Positive Squamous Cell Anal Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07480928
What this trial is testing

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech 42
Early research (Phase 1)Study completedNCT03450122
What this trial is testing

Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

Who this might be right for
HLA-A*0201 Positive Cells PresentNY-ESO-1 Positive Tumor Cells PresentRecurrent Myxoid Liposarcoma+1 more
M.D. Anderson Cancer Center 15
Early research (Phase 1)Ended earlyNCT00611637
What this trial is testing

CMV pp65 Specific T Cell Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation for Malignant Disease

Who this might be right for
Allogeneic Stem Cell Transplantation
H. Kim Lyerly 2
Early research (Phase 1)WithdrawnNCT06572631
What this trial is testing

Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic SyndromeRefractory Acute Myeloid Leukemia+1 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT00045357
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT07744256
What this trial is testing

Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)Relapsed/Refractory SCLCExtensive-stage SCLC
Beijing Biotech 60
Not applicableUnknownNCT04351659
What this trial is testing

Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

Who this might be right for
COVID-19
KK Women's and Children's Hospital 8
Testing effectiveness (Phase 2)WithdrawnNCT03419559
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Iovance Biotherapeutics, Inc.
Testing effectiveness (Phase 2)UnknownNCT02632019
What this trial is testing

Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary Tract

Who this might be right for
Advanced Biliary Tract Malignant Tumor
Second Military Medical University 40
Next Page